Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Capsule for subsequent filainous uveitis after cataract surgery

A technology for uveitis and fibrosis, applied in the direction of capsule delivery, organic active ingredients, and medical preparations containing active ingredients, etc., can solve the problems of complex pre-control of cataracts, improve eye circulation disorders, relieve pain, Enhance the effect of retinal metabolism

Inactive Publication Date: 2016-10-26
钟志敏
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, systemic antibiotics are mostly used in the treatment of this disease in order to control inflammation and absorb all the cellulose exudate. However, the prevention and control of cataract surgery is complicated. Simple control of inflammation cannot fundamentally solve the postoperative complications of cataract patients. In order to control the symptoms, we need to find better drugs to control the symptoms and promote the visual recovery of cataract patients after surgery.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] A capsule for fibrous uveitis after cataract surgery, mainly composed of the following components by weight: 0.3 parts of acetazolamide, 0.2 parts of taurine, 5.2 parts of aucubin, hyperoside 4.7 parts, L-fucose 4.3 parts, wogonin 3.8 parts, water-soluble nutritional pigment 3.5 parts, caffeic acid 2.9 parts, β-sitosterol 2.6 parts, baicalin 2.2 parts, pearl powder 2.0 parts, ursolic acid 1.3 parts, 1.2 parts of D-mannitol, 0.015 parts of vitamin C, 0.008 parts of vitamin A, 4 parts of diluent, 0.4 parts of lubricant, 0.2 parts of glidant, 2 parts of disintegrant, and 1.0 part of wetting agent.

[0018] Wherein, the water-soluble nutrient pigment is formed by mixing crocetin and β-carotene in a mass ratio of 2:3, which not only has anti-oxidation, anti-depression and anti-cancer activities, but also can prevent cataracts and protect eyes The fiber part of the crystal can strengthen the immune system of the body and enhance the resistance after cataract surgery; the pear...

Embodiment 2

[0023] A capsule for fibrous uveitis after cataract surgery, mainly composed of the following components by weight: 0.6 parts of acetazolamide, 0.5 parts of taurine, 9.4 parts of aucubin, hyperoside 8.6 parts, L-fucose 8.1 parts, wogonin 7.2 parts, water-soluble nutritional pigment 6.8 parts, caffeic acid 6.3 parts, β-sitosterol 5.9 parts, baicalin 5.4 parts, pearl powder 5.0 parts, ursolic acid 3.9 parts, 3.7 parts of D-mannitol, 0.021 parts of vitamin C, 0.014 parts of vitamin A, 7.5 parts of diluent, 0.8 parts of lubricant, 0.4 parts of glidant, 5.5 parts of disintegrant, and 2.25 parts of wetting agent.

[0024] Wherein, the water-soluble nutrient pigment is formed by mixing crocetin and β-carotene in a mass ratio of 2:3, which not only has anti-oxidation, anti-depression and anti-cancer activities, but also can prevent cataracts and protect eyes The fiber part of the crystal can strengthen the immune system of the body and enhance the resistance after cataract surgery; th...

Embodiment 3

[0029] A capsule for fibrous uveitis after cataract surgery, mainly composed of the following components by weight: 0.9 parts of acetazolamide, 0.8 parts of taurine, 13.6 parts of aucubin, hyperoside 12.5 parts, L-fucose 11.9 parts, wogonin 10.6 parts, water-soluble nutritional pigment 10.1 parts, caffeic acid 9.7 parts, β-sitosterol 9.2 parts, baicalin 8.6 parts, pearl powder 8.0 parts, ursolic acid 6.5 parts, D-mannitol 6.2 parts, vitamin C 0.027 parts, vitamin A 0.020 parts, diluent 11 parts, lubricant 1.2 parts, glidant 0.6 parts, disintegrant 9 parts, wetting agent 3.5 parts.

[0030] Wherein, the water-soluble nutrient pigment is formed by mixing crocetin and β-carotene in a mass ratio of 2:3, which not only has anti-oxidation, anti-depression and anti-cancer activities, but also can prevent cataracts and protect eyes The fiber part of the crystal can strengthen the immune system of the body and enhance the resistance after cataract surgery; the pearl powder is to take c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a capsule for subsequent filainous uveitis after cataract surgery. The capsule is mainly prepared from the following components: acetazolamide, taurine, aucubin, hyperoside, L-fucose, wogonin, water-soluble nutrient pigment, caffeic acid, beta-sitosterol, baicalein, pearl powder, ursolic acid, D-mannitol, vitamin A, vitamin C, diluent, lubricant, glidant, disintegrant and a wetting agent. According to the capsule, ocular circulatory disturbance can be improved, inflammatory response can be controlled, and retinal metabolism and immunoregulation functions can be enhanced, so that absorption of postoperative hyperplastic lesions can be promoted, inflammatory fibrous exudation can be inhibited, and vision recovery after cataract surgery can be promoted. The capsule has a remarkable curative effect, and is suitable for popularization.

Description

technical field [0001] The invention relates to the technical field of ophthalmic medicine, in particular to a capsule for fibrous uveitis after cataract surgery. Background technique [0002] Cataract is not an unfamiliar term in modern medicine. All kinds of reasons, such as aging, heredity, local nutritional disorders, abnormal immunity and metabolism, trauma, poisoning, radiation, etc., can cause lens metabolic disorders, resulting in lens protein denaturation and turbidity. , called a cataract, when light is blocked by the cloudy lens from reaching the retina, causing blurred vision. With the environment, work pressure, frequent accidents and other factors, there are more and more cataract patients, but at present, there are no systematic and mature treatment methods for cataract at home and abroad, and most of them are still in the stage of exploration and research. Under the premise of seeing the effect, most doctors will choose to use surgical treatment, hoping to c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/618A61K9/48A61P27/12A61P27/02A61K31/7048A61K31/7004A61K31/575A61K31/56A61K31/433A61K31/375A61K31/352A61K31/192A61K31/185A61K31/07A61K31/047A61K31/7024A61K31/015
CPCA61K35/618A61K9/4866A61K31/015A61K31/047A61K31/07A61K31/185A61K31/192A61K31/352A61K31/375A61K31/433A61K31/56A61K31/575A61K31/7004A61K31/7024A61K31/7048A61K2300/00
Inventor 钟志敏
Owner 钟志敏
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products